Foresters Investment Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | $23.1M | Sell |
174,650
-29,850
| -15% | -$3.95M | 0.46% | 67 |
|
|
2019
Q2 | $29M | Sell |
204,500
-7,450
| -4% | -$1.06M | 0.52% | 57 |
|
|
2019
Q1 | $30.8M | Buy |
211,950
+31,150
| +17% | +$4.52M | 0.54% | 60 |
|
|
2018
Q4 | $20.5M | Buy |
180,800
+23,200
| +15% | +$2.63M | 0.39% | 84 |
|
|
2018
Q3 | $21.2M | Sell |
157,600
-2,900
| -2% | -$390K | 0.34% | 100 |
|
|
2018
Q2 | $18M | Buy |
160,500
+7,900
| +5% | +$887K | 0.31% | 119 |
|
|
2018
Q1 | $16.3M | Buy |
152,600
+1,100
| +0.7% | +$117K | 0.27% | 134 |
|
|
2017
Q4 | $16.6M | Sell |
151,500
-13,400
| -8% | -$1.47M | 0.26% | 137 |
|
|
2017
Q3 | $17.8M | Buy |
164,900
+1,100
| +0.7% | +$119K | 0.29% | 131 |
|
|
2017
Q2 | $16.6M | Buy |
163,800
+2,800
| +2% | +$283K | 0.28% | 130 |
|
|
2017
Q1 | $14.5M | Buy |
161,000
+200
| +0.1% | +$18K | 0.25% | 145 |
|
|
2016
Q4 | $12.2M | Buy |
160,800
+31,100
| +24% | +$2.35M | 0.22% | 153 |
|
|
2016
Q3 | $10.8M | Buy |
129,700
+1,000
| +0.8% | +$83.3K | 0.2% | 153 |
|
|
2016
Q2 | $10.6M | Buy |
128,700
+7,400
| +6% | +$610K | 0.2% | 149 |
|
|
2016
Q1 | $9.21M | Buy |
+121,300
| New | +$9.21M | 0.19% | 149 |
|